Detalhe da pesquisa
1.
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma.
Int J Mol Sci
; 25(4)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397007
2.
Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight.
Cancer Sci
; 114(5): 2087-2097, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36704833
3.
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis.
Invest New Drugs
; 41(3): 512-521, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171720
4.
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury.
J Gastroenterol Hepatol
; 38(2): 251-258, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302734
5.
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Cancer Invest
; 40(2): 189-198, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34658277
6.
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis.
BMC Cancer
; 22(1): 654, 2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698083
7.
CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.
Cancer Sci
; 112(7): 2770-2780, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934437
8.
Comparing incidences of infusion site reactions between brand-name and generic vinorelbine in patients with non-small cell lung cancer.
Br J Clin Pharmacol
; 87(3): 1318-1326, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32790917
9.
Efficacies of programmed cell death 1 ligand 1 blockade in non-small cell lung cancer patients with acquired resistance to prior programmed cell death 1 inhibitor and development of diabetic ketoacidosis caused by two different etiologies: a retrospective case series.
Endocr J
; 68(5): 613-620, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790087
10.
Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: A prospective cohort study.
Int J Cancer
; 146(12): 3504-3515, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31846063
11.
Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double-positive lung cancer.
Cancer Sci
; 111(2): 561-570, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31782583
12.
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.
Br J Cancer
; 122(6): 771-777, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32009131
13.
Primary Prophylaxis Indication for Docetaxel Induced Febrile Neutropenia in Elderly Patients with Non-Small Cell Lung Cancer.
Cancer Invest
; 38(7): 424-430, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32643445
14.
UHRF1, a Regulator of Methylation, as a Diagnostic and Prognostic Marker for Lung Cancer.
Cancer Invest
; 38(4): 240-249, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212938
15.
Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.
Int J Clin Oncol
; 25(11): 1928-1935, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32740717
16.
BK virus-associated viruria and viremia in a patient with lymphangioleiomyomatosis after lung re-transplantation: A case report and review of the literature on BK virus infection post-lung transplantation.
J Infect Chemother
; 25(10): 820-824, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31027885
17.
eIF2ß, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
Cancer Sci
; 109(6): 1843-1852, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624814
18.
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
Cancer Sci
; 108(4): 732-743, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28165654
19.
Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L).
Ther Adv Med Oncol
; 16: 17588359231225046, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38282663
20.
Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review.
Int Cancer Conf J
; 13(2): 88-92, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38524642